Acute pancreatitis: Difference between revisions
Ostermayer (talk | contribs) (references) |
Ostermayer (talk | contribs) (→Source) |
||
| Line 131: | Line 131: | ||
#All other patients should be admitted | #All other patients should be admitted | ||
== | ==References== | ||
Tintinalli | Tintinalli | ||
<references/> | |||
[[Category:GI]] | [[Category:GI]] | ||
Revision as of 23:09, 1 January 2014
Background
- Acute inflammatory process that may involve surrounding tissue and remote organ systems
- Disease can range from mild inflammation to severe necrosis and multi-organ failure
Etiology
- Gallstone (including microlithiasis) - 35-40% of cases
- Alcohol (acute and chronic consumption)
- Hypertriglyceridemia
- ERCP
- Drugs
- Azathioprine, cisplatin, furosemide, tetracycline, thiazides, sulfa
- Autoimmune disease
- SLE, Sjögren
- Abdominal trauma
- Postoperative complications
- Infection
- Bacterial: Legionella, Leptospira, Mycoplasma, Salmonella
- Viral: mumps,coxsackie, CMV, echo, Hep B
- Parasitic: Ascaris, cryptosporidium, toxoplasma
- Hypercalcemia
- Hyperparathyroidism
- Ischemia
- Posterior penetrating ulcer
- Scorpion venom
- Organophosphate insecticide
- Pancreatic or ampullary tumor
- Pancreas divisum with ductular narrowing on pancreatogram
- Oddi sphincter dysfunction
- Idiopathic (15-20% of cases)
DDX
Clinical Features
- Pain
- Persistent
- Localizes to epigastric area, around waist, RUQ, or occasionally LUQ
- Radiates to back
- N/V noted in most
- Abd distention is frequent complaint
- Cullen sign (ecchymosis of periumbilical region) - intrabdominal hemorrhage
- Turner sign (ecchymosis of flanks) - retroperitoneal hemorrhage
- Pulmonary Findings
- Hypoxemia, ARDS, tachypnea
- Indicates severe pancreatitis
- Diaphragmatic inflammation, pancreatico-pleural fistula
Diagnosis
- Two of the following 3 features:
- 1. Characteristic abdominal pain
- 2. Lipase level 3x upper limit of normal
- Negative lipase does not exclude pancreatitis in chronic/recurrent disease
- Absolute value not associated w/ prognosis or severity
- Negative lipase does not exclude pancreatitis in chronic/recurrent disease
- 3. Characteristic findings on US or CT
- Imaging
- Ultrasound
- Edematous, swollen pancreas
- Gallstones
- Pseudocyst / pancreatic abscess
- CT w/ IV contrast
- Helpful to exclude alternative diagnoses, assess severity, identify complications
- ERCP
- Indicated for pts w/ severe biliary pancreatitis w/ retained CBD stone or cholangitis
- Ultrasound
Work-Up
- Lipase
- CBC
- Chemistry
- LFT
- ?Lactate
- ?Triglyceride
Treatment
"Place the pancreas at rest"
- NPO (clears is probably ok for mild/moderate cases)
- IVF
- Maintain urine output at 0.5 mL/kg
- Analgesia
- Antiemetics
- Hypocalcemia
- Treat if symptomatic
- Glycemic control
- Albumin
- Consider if level <2
- NGT if ileus is present
- Abx[1] [2][3][4][5]
- Only indicated for necrosis, abscess, or infected pseudocyst / peripancreatic fluid
- Imipenem-cilastatin, meropenem, or (fluoroquinolone + metronidazole)
- ERCP
- Indicated for retained CBD stones or cholangitis
Complications
- Local
- Pancreatic necrosis
- Pancreatic pseudocyst / abscess
- Portal vein thrombosis
- Systemic
- Cardiac dysfunction
- Renal failure
- Respiratory failure
- Shock
- Hypocalcemia (due to sequestration in necrotic fat)
- Hyperglycemia
Prognosis
- APACHE-II
- Highest sensitivity and specificity in distinguishing mild from severe pancreatitis
- Can be used to estimate risk of hospital death at admission
- http://www.globalrph.com/apacheii.htm
- CT Severity Index
- Ranson criteria
- Consist of 11 parameters. Five of the factors are assessed at admission, and six of the factors are assessed during the next 48 hours.
- On admission:
- Age > 55
- WBC > 16,000
- Blood glucose >200mg/dL
- Lactate dehydrogenase >350 U/L
- Aspartate aminotransferase (AST) >250 U/L
- 48 hours:
- Hematocrit fall by > 10%
- BUN increase by >5 mg/dL
- Serum Calcium <8 mg/dL
- pO2 < 60mmHg
- Base deficit >4 MEq/L
- Fluid Sequestation > 6L
Disposition
- Discharge
- Mild case + no biliary disease + no systemic complication + tolerating clears
- All other patients should be admitted
References
Tintinalli
- ↑ Bassi C, Larvin M, Villatoro E. Antibiotic therapy for prophylaxis against infection of pancreatic necrosis in acute pancreatitis. Cochrane Database Syst Rev.2003; Issue 4, CD002941.
- ↑ Golub R, Siddiqi F, Pohl D. Role of antibiotics in acute pancreatitis: a meta-analysis. J Gastrointest Surg. 1998;2:496–503.
- ↑ Sharma VK, Howden CW. Prophylactic antibiotic administration reduces sepsis and mortality in acute necrotizing pancreatitis: a meta-analysis. Pancreas. 2001;22:28–31
- ↑ Zhou YM, Xue ZL, Li YM, et al. Antibiotic prophylaxis in patients with severe acute pancreatitis. Hepatobiliary Pancreat Dis Int. 2005;4:23–27
- ↑ Manes G, Rabitti PG, Menchise A, et al. Prophylaxis with meropenem of septic complications in acute pancreatitis: a randomized, controlled trial versus imipenem. Pancreas. 2003;27:79–83
